David Bevan

Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B

Amit Nathwani, Ulreke M. Reiss, Edward G. D. Tuddenham et al. · New England Journal of Medicine · 2014 · 1.3K citations · Full text

Medicine, Genetics, Molecular Genetics +17

Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features

Marie Scully, Helen Yarranton, Ri Liesner et al. · British Journal of Haematology · 2008 · 376 citations

Medicine, Hematology, Internal Medicine +7

MALIGNANT HISTIOCYTOSIS OF THE INTESTINE: A T-CELL LYMPHOMA

P G Isaacson, Jo Spencer, C. E. Connolly et al. · The Lancet · 1985 · 359 citations

Medicine, Oncology, Pathology +14

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

John Pasi, Savita Rangarajan, Pencho Georgiev et al. · New England Journal of Medicine · 2017 · 357 citations · Full text

Medicine, Hematology, Molecular Biology +15

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A

Barbara A. Konkle, Oleksandra Stasyshyn, Pratima Chowdary et al. · Blood · 2015 · 255 citations · Full text

Medicine, Hematology, Pharmacotherapy +15